- Postdoctoral Associate, Scripps Research Institute, 2001-2003
- PhD, Purdue University, 2001
- BS, University of Illinois, 1997
The foremost focus of our research is the synthesis of complex, biologically active natural products. Considerable emphasis will also be placed on the discovery and development of new reactions and synthetic methods for achieving high levels of enantioselective control.
For example, many useful carbon-carbon bond-forming reactions exist; however, conditions for the corresponding asymmetric variants are often under-developed or unexplored. At the core of this research program is the enantioselective development of the [2,3]-Wittig rearrangement and asymmetric alkylation of acyclic carbonyl compounds utilizing novel chiral amine-based ligands derived from a sulfamidate template. With respect to natural products, current targets of interest include Lasonolide A, Didemnaketal A, Caylobolide A, and Miyakolide.
The importance of total synthesis of biologically active natural products and methodology development provides an excellent educational opportunity to all post-graduate, graduate, and undergraduate students for their future careers in academia and the pharmaceutical or chemical industry.
Dr. Jennings’ publication list.